|
|||||
|
|
A pilot study of the effect of rivaroxaban in sickle cell anemia |
|
| Authors: | Kenneth I. Ataga Laila Elsherif David Wichlan Adane F. Wogu Neil Matsui Rafal Pawlinski Jianwen Cai Nigel S. Key |
| Affiliation: | 1. Center for Sickle Cell Disease, University of Tennessee Health Scienter Center, Memphis, Tennessee, USA;2. Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA;3. Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA;4. Vanguard Therapeutics, Inc., Half Moon Bay, California, USA |
| Abstract: | |
| Keywords: | coagulation activation inflammation microvascular flow rivaroxaban sickle cell disease |